WO2005072505A3 - Methods and compositions for the treatment of skin changes associated with aging and environmental damage - Google Patents

Methods and compositions for the treatment of skin changes associated with aging and environmental damage Download PDF

Info

Publication number
WO2005072505A3
WO2005072505A3 PCT/US2005/000972 US2005000972W WO2005072505A3 WO 2005072505 A3 WO2005072505 A3 WO 2005072505A3 US 2005000972 W US2005000972 W US 2005000972W WO 2005072505 A3 WO2005072505 A3 WO 2005072505A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin
compositions
compound
methods
aging
Prior art date
Application number
PCT/US2005/000972
Other languages
French (fr)
Other versions
WO2005072505A2 (en
Inventor
Louis B Fisher
Original Assignee
Mary Kay Inc
Louis B Fisher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mary Kay Inc, Louis B Fisher filed Critical Mary Kay Inc
Priority to CA002545501A priority Critical patent/CA2545501A1/en
Priority to BRPI0506665-4A priority patent/BRPI0506665A/en
Priority to EP05705570A priority patent/EP1706092A2/en
Priority to MXPA06008239A priority patent/MXPA06008239A/en
Priority to EA200601262A priority patent/EA200601262A1/en
Priority to AU2005208491A priority patent/AU2005208491A1/en
Publication of WO2005072505A2 publication Critical patent/WO2005072505A2/en
Publication of WO2005072505A3 publication Critical patent/WO2005072505A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Abstract

The present invention relates to novel methods and compositions comprising a combination of ingredients for treating aged, mature, nutritionally-compromised, or environmentally-damaged skin. These methods and compositions provide improvements in the skin's visual appearance, physiological functions, clinical properties, and biophysical properties. The compositions of the present invention can include, for example, a compound that stimulates microcirculation through the skin, a compound that stimulates the immune system, a compound that reduces ultraviolet light or sun exposure damage, a compound that evens out the pigmentation of the skin, and/or a compound that improves the barrier properties of the skin.
PCT/US2005/000972 2004-01-21 2005-01-13 Methods and compositions for the treatment of skin changes associated with aging and environmental damage WO2005072505A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002545501A CA2545501A1 (en) 2004-01-21 2005-01-13 Methods and compositions for the treatment of skin changes associated with aging and environmental damage
BRPI0506665-4A BRPI0506665A (en) 2004-01-21 2005-01-13 processes and compositions for treating skin changes associated with aging and environmental damage
EP05705570A EP1706092A2 (en) 2004-01-21 2005-01-13 Methods and compositions for the treatment of skin changes associated with aging and environmental damage
MXPA06008239A MXPA06008239A (en) 2004-01-21 2005-01-13 Methods and compositions for the treatment of skin changes associated with aging and environmental damage.
EA200601262A EA200601262A1 (en) 2004-01-21 2005-01-13 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CHANGES IN SKIN RELATED TO AGING AND DAMAGE DUE TO ENVIRONMENTAL CONDITIONS
AU2005208491A AU2005208491A1 (en) 2004-01-21 2005-01-13 Methods and compositions for the treatment of skin changes associated with aging and environmental damage

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/761,810 US20050158258A1 (en) 2004-01-21 2004-01-21 Methods and compositions for the treatment of skin changes associated with aging and environmental damage
US10/761,810 2004-01-21

Publications (2)

Publication Number Publication Date
WO2005072505A2 WO2005072505A2 (en) 2005-08-11
WO2005072505A3 true WO2005072505A3 (en) 2005-10-13

Family

ID=34750258

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/000972 WO2005072505A2 (en) 2004-01-21 2005-01-13 Methods and compositions for the treatment of skin changes associated with aging and environmental damage

Country Status (11)

Country Link
US (1) US20050158258A1 (en)
EP (1) EP1706092A2 (en)
CN (1) CN1905891A (en)
AR (1) AR047513A1 (en)
AU (1) AU2005208491A1 (en)
BR (1) BRPI0506665A (en)
CA (1) CA2545501A1 (en)
EA (1) EA200601262A1 (en)
MX (1) MXPA06008239A (en)
TW (1) TW200538155A (en)
WO (1) WO2005072505A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20014256D0 (en) * 2001-09-03 2001-09-03 Bjoern Kristiansen Preparation of immunostimulatory compound
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
WO2005016364A1 (en) * 2003-08-14 2005-02-24 Guthy-Renker Corporation Skin care composition including hexapeptide complexes and methods of their manufacture
US7514085B2 (en) * 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
WO2006119774A1 (en) * 2005-05-13 2006-11-16 Medimush As Feed or food products comprising fungal material
US9072776B2 (en) * 2005-06-15 2015-07-07 Glycanova As Anti-cancer combination treatment and kit-of-parts
WO2006133708A1 (en) * 2005-06-15 2006-12-21 Medimush A/S Bioactive agents produced by submerged cultivation of a basidiomycete cell
DE102005061071A1 (en) * 2005-12-21 2007-06-28 Kneipp-Werke Kneipp-Mittel-Zentrale Gmbh & Co. Kg Drug combination of Santalbinsäure or derivatives thereof and grape seed oil for topical or dermatological use
EA017935B1 (en) 2006-05-19 2013-04-30 Мэри Кэй Инк. Composition for skin care and use thereof
US20130115320A1 (en) 2007-03-30 2013-05-09 Dynova Laboratories, Inc. Therapeutic agent for intranasal administration and method of making and using same
US20080241290A1 (en) * 2007-03-30 2008-10-02 Wayne Jeffrey Perry Sinus relief composition and method of producing the same
US20080242741A1 (en) * 2007-03-30 2008-10-02 Wayne Jeffrey Perry Intranasal drug delivery system
US20090053319A1 (en) * 2007-08-21 2009-02-26 Wayne Jeffrey Perry Sore Throat Relief Composition And Method of Producing Same
US20090069446A1 (en) * 2007-09-06 2009-03-12 Wayne Jeffrey Perry Dendritic salt therapeutic agent delivery system
CA2639512A1 (en) * 2007-09-10 2009-03-10 Sicap Industries, Llc Nasal rinse additive
JP5176502B2 (en) * 2007-11-30 2013-04-03 澁谷工業株式会社 Container sterilizer
FR2930446B1 (en) * 2008-04-29 2012-06-08 Am Phyto Conseil USE OF A COMPOSITION CONTAINING ERGOSTEROL OR A NATURAL EXTRACT OF MICROORGANISM OR PLANT OR ANIMAL.
KR101114161B1 (en) * 2009-01-28 2012-02-22 (주)아모레퍼시픽 Body Detergent composition for moisturizing or soothing the skin containing Aloe barbadensis miller extract and Althaea officinalis root extract
DE202012012801U1 (en) * 2011-05-10 2014-02-17 Mary Kay Inc. cosmetic compositions
AU2012286671B2 (en) * 2011-07-28 2017-07-20 Santalis Pharmaceuticals Inc. Sandalwood oil and its uses related to skin disorders
KR102158895B1 (en) 2013-03-12 2020-09-22 마리 케이 인코포레이티드 Preservative system
JP2016513650A (en) * 2013-03-13 2016-05-16 ビロクシス コーポレイション Stabilized cream formulation containing sandalwood oil
MX2017005108A (en) * 2014-10-31 2018-03-06 Pomega Inc Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract.
ES2710719T3 (en) * 2015-02-16 2019-04-26 Frezyderm S A Composition of anhydrous solar protection complete with underwater technology
EP3359176A4 (en) 2015-10-07 2019-06-12 Santalis Pharmaceuticals Inc. Sandalwood oil and its uses related to oral mucositis

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2633516A1 (en) * 1988-06-30 1990-01-05 Clarins Cosmetic composition for the treatment of dehydrated sensitive skins
US5104655A (en) * 1987-07-27 1992-04-14 Indena S.P.A. Polyunsaturated acids having vasokinetic action and pharmaceutical and cosmetic formulations containing them
JPH11263732A (en) * 1998-03-16 1999-09-28 Ichimaru Pharcos Co Ltd Skin preparation for external use containing mushroom extracts
US6475536B2 (en) * 1996-10-17 2002-11-05 Indena S.P.A. Pharmaceutical and cosmetic formulations with antimicrobial activity
US20030072777A1 (en) * 2001-10-05 2003-04-17 Maes Daniel H. Combinatorial anti-acne compositions
US20040121979A1 (en) * 2001-04-30 2004-06-24 Rudy Susilo Pharmaceutically active uridine esters
US20040161435A1 (en) * 2003-02-14 2004-08-19 Gupta Shyam K. Skin Firming Anti-Aging Cosmetic Mask Compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
US6248763B1 (en) * 1998-05-19 2001-06-19 Scivoletto Rosemarie Composition for treating skin conditions
US6365623B1 (en) * 1997-11-17 2002-04-02 Nicholas V. Perricone Treatment of acne using lipoic acid
US6495126B1 (en) * 1999-07-20 2002-12-17 Mary Kay Inc. Treatment and composition for achieving skin anti-aging benefits by corneum protease activation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104655A (en) * 1987-07-27 1992-04-14 Indena S.P.A. Polyunsaturated acids having vasokinetic action and pharmaceutical and cosmetic formulations containing them
FR2633516A1 (en) * 1988-06-30 1990-01-05 Clarins Cosmetic composition for the treatment of dehydrated sensitive skins
US6475536B2 (en) * 1996-10-17 2002-11-05 Indena S.P.A. Pharmaceutical and cosmetic formulations with antimicrobial activity
JPH11263732A (en) * 1998-03-16 1999-09-28 Ichimaru Pharcos Co Ltd Skin preparation for external use containing mushroom extracts
US20040121979A1 (en) * 2001-04-30 2004-06-24 Rudy Susilo Pharmaceutically active uridine esters
US20030072777A1 (en) * 2001-10-05 2003-04-17 Maes Daniel H. Combinatorial anti-acne compositions
US20040161435A1 (en) * 2003-02-14 2004-08-19 Gupta Shyam K. Skin Firming Anti-Aging Cosmetic Mask Compositions

Also Published As

Publication number Publication date
TW200538155A (en) 2005-12-01
WO2005072505A2 (en) 2005-08-11
AR047513A1 (en) 2006-01-25
EP1706092A2 (en) 2006-10-04
EA200601262A1 (en) 2006-12-29
CN1905891A (en) 2007-01-31
AU2005208491A1 (en) 2005-08-11
CA2545501A1 (en) 2005-08-11
BRPI0506665A (en) 2007-06-12
MXPA06008239A (en) 2007-01-26
US20050158258A1 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
WO2005072505A3 (en) Methods and compositions for the treatment of skin changes associated with aging and environmental damage
WO2005055736A3 (en) Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
WO2006031555A3 (en) Compositions and methods for treatment of skin discoloration
CA2338091A1 (en) Method of conditioning the skin
WO2007084998A3 (en) Compositions comprising kakadu plum extract or acai berry extract
CA2588128C (en) Compositions and methods of their use for improving the condition and appearance of skin
WO2003017826A3 (en) Processed soft tissue for topical or internal application
MXPA02011912A (en) Lightening compositions and methods of use.
WO2006068779A3 (en) Compositions and methods of their use for improving the condition and appearance of skin
WO1999043296A3 (en) Anti-irritants in cosmetic compositions
EP1506772A3 (en) Aesthetically and SPF improved UV sunscreens comprising glass microspheres
AU2003275419A1 (en) Lotus and methyl donors
WO2001066076A3 (en) Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions
WO2004080380A3 (en) Use of catechuic polyphenols for preparing compositions for stimulating a skin's natural pigmentation
WO2005037323A3 (en) Use of gro to treat or prevent inflammation
WO2005051288A3 (en) Compositions for achieving benefits in skin using key cellular metabolic intermediates
WO2005020877A3 (en) Use of biotin or a biotin derivative for lightening skin and treating age spots
AU7067200A (en) Skin care compositions and treatments
WO2004096216A3 (en) Use of a topical medicament comprising riluzole
WO2006004695A3 (en) Cosmetic compositions and methods comprising rhodiola rosea
MX9801733A (en) Skin moisturizing and protective cosmetic compositions.
WO2004071538A3 (en) Topical delivery of cosmetic agents
DE69900950D1 (en) Cosmetic and / or dermatological powder composition, as well as processes for their preparation and their use
AU2002366433A1 (en) Methods and compositions for treating metabolic bone diseases relating to human endokine alpha
PT1390007E (en) Cosmetic composition based on zinc and copper sulphates and sucralphate

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200580001721.3

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2545501

Country of ref document: CA

Ref document number: 2005208491

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2005705570

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2005208491

Country of ref document: AU

Date of ref document: 20050113

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005208491

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/008239

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 200601262

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 1020067016769

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2005705570

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020067016769

Country of ref document: KR

ENP Entry into the national phase

Ref document number: PI0506665

Country of ref document: BR